Active ingredientEptifibatideCat. No. P-E075-001CAS 188627-80-7Family · Pharmaceutical analytical standards
Eptifibatide
An antiplatelet drug, a small cyclic peptide that blocks the platelet glycoprotein IIb/IIIa receptor: approved in the United States in 1998, it is given intravenously in acute coronary syndromes and during angioplasty. This family brings together the active ingredient and other impurities.
Did you know?It is modelled on a protein from the venom of the southeastern pygmy rattlesnake, Sistrurus miliarius barbouri, a small rattlesnake of the south-eastern United States.
Go to the active ingredient →Active ingredientEptifibatideCat. No. P-E075-001CAS 188627-80-7
Active ingredientEptifibatide AcetateCat. No. P-E075-002CAS 881997-86-0
ImpurityEptifibatide Impurity 1Cat. No. P-E075-007
ImpurityEptifibatide Impurity 2Cat. No. P-E075-009
ImpurityEptifibatide Impurity 3Cat. No. P-E075-010
ImpurityEptifibatide Impurity 4Cat. No. P-E075-012No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.